Irritable bowel syndrome
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Between the ages of 18 and 75, male and female; It met the diagnostic criteria of Rome ? diarrheal IBS subtype; It meets the diagnosis standard of the syndrome of liver stagnation and spleen deficiency in traditional Chinese medicine; The baseline IBS-SSS score is not less than 75; Patients volunteered to participate in the study and signed informed consent.
Exclusion criteria
Exclusion criteria: Diarrhoea due to other clearly diagnosed diseases, such as peptic ulcer disease, inflammatory bowel disease, tumour, etc.; Patients with serious diseases of liver, kidney, nerve, cardiovascular, respiratory and other organs or systems; Allergic to the drugs used in the protocol; Women in pregnancy; Mental illness, intellectual disability, education level and other reasons can not be surveyed; Those who have received drugs that may affect the judgment of curative effect in the past week, such as antispasmodic drugs, antidiarrhoetics, probiotics, antibiotics, anti-depressant and anxiety drugs, etc.; Patients with severe skin diseases, skin damage or poor glycemic control in the application area; Patients who are enrolled in another clinical trial or have completed another clinical trial for less than 3 months. Those who satisfy one or more of the above requirements will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The Irritable bowel Syndrome Severity Score Scale; | — |
Secondary
| Measure | Time frame |
|---|---|
| Hamilton Depression Scale;The Irritable Bowel Syndrome Quality of Life;Hamilton Anxiety Scale;TCM syndrome score scale;Bristol Fecal Trait Scale; | — |
Countries
China